SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-110185
Filing Date
2020-09-30
Accepted
2020-09-30 08:19:30
Documents
14
Period of Report
2020-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2031940d2_8k.htm   iXBRL 8-K 40675
2 EXHIBIT 4.1 tm2031940d2_ex4-1.htm EX-4.1 626151
3 EXHIBIT 5.1 tm2031940d2_ex5-1.htm EX-5.1 9856
  Complete submission text file 0001104659-20-110185.txt   983952

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gild-20200930.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20200930_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20200930_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2031940d2_8k_htm.xml XML 3499
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 201210669
SIC: 2836 Biological Products, (No Diagnostic Substances)